GRP
CGTX icon

Global Retirement Partners’s Cognition Therapeutics CGTX Stock Holding History

Global Retirement Partners’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.3K Buy
+2,000
New +$2.37K ﹤0.01% 3961
2025
Q4 		$2.7K Hold
2,000
– – ﹤0.01% 3637
2025
Q3 		$2.7K Buy
+2,000
New +$2.73K ﹤0.01% 3211

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Global Retirement Partners's CGTX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Cognition Therapeutics (CGTX) in Q2 2026: 2,000 shares worth $2.3K. The stake represents ﹤0.01% of the portfolio and ranks #3961 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in CGTX as recently as Q4 2025.

Global Retirement Partners first reported a position in CGTX in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.7K in Q4 2025. 66 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

  • Global Retirement Partners held 2,000 shares of Cognition Therapeutics worth $2.3K as of Q2 2026.
  • Cognition Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Cognition Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3961 holding.
  • Global Retirement Partners first reported a position in Cognition Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Global Retirement Partners's Cognition Therapeutics position peaked at $2.7K in Q4 2025.
  • 66 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.